These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 10449301)
1. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction. Escaut L; Liotier JY; Albengres E; Cheminot N; Vittecoq D AIDS; 1999 Jul; 13(11):1419-20. PubMed ID: 10449301 [No Abstract] [Full Text] [Related]
3. Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity. Frissen PH; de Vries J; Weigel HM; Brinkman K AIDS; 2001 Jan; 15(2):289. PubMed ID: 11216946 [No Abstract] [Full Text] [Related]
4. A near-fatal hypersensitivity reaction to abacavir: case report and literature review. Shapiro M; Ward KM; Stern JJ AIDS Read; 2001 Apr; 11(4):222-6. PubMed ID: 11392679 [TBL] [Abstract][Full Text] [Related]
5. Chronic cough induced by abacavir apart from a context of hypersensitivity. Peyrière H; Mauboussin JM; Arnaud A; Rouanet I; Vincent D Allerg Immunol (Paris); 2002 Dec; 34(10):359-60. PubMed ID: 12575618 [TBL] [Abstract][Full Text] [Related]
6. Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients. Bellagamba R; Tommasi C; De Marco M; Narciso P J Infect; 2008 Jul; 57(1):88-90. PubMed ID: 18514915 [No Abstract] [Full Text] [Related]
7. 1592 (abacavir): do not rechallenge after hypersensitivity reaction. James JS AIDS Treat News; 1997 Dec; (No 285):1, 5. PubMed ID: 11364916 [TBL] [Abstract][Full Text] [Related]
8. Unusual clinical presentation of hypersensitivity reaction to abacavir. Aquilina C; Mularczyk M; Lucas F; Viraben R AIDS; 2003 Nov; 17(16):2403-4. PubMed ID: 14571198 [No Abstract] [Full Text] [Related]
9. Agranulocytosis and fever seven weeks after starting abacavir. Sankatsing SU; Prins JM AIDS; 2001 Dec; 15(18):2464-5. PubMed ID: 11774836 [No Abstract] [Full Text] [Related]
13. Understanding drug hypersensitivity: what to look for when prescribing abacavir. Hetherington S AIDS Read; 2001 Dec; 11(12):620-2. PubMed ID: 11806176 [TBL] [Abstract][Full Text] [Related]
14. Current trends in screening across ethnicities for hypersensitivity to abacavir. Rodriguez-Nóvoa S; Soriano V Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539 [TBL] [Abstract][Full Text] [Related]
15. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience. Waters LJ; Mandalia S; Gazzard B; Nelson M AIDS; 2007 Nov; 21(18):2533-4. PubMed ID: 18025891 [TBL] [Abstract][Full Text] [Related]